Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Methotrexate | 0.31623 | uM | 4 | 312.50 | 180.13 | 287.00 | 247.75 | 1.1584 | 1.7536 |
| SK-BR-3 | Taxol | 0.00016596 | uM | 4 | 312.50 | 180.13 | 273.00 | 247.75 | 1.1019 | 1.4699 |
| SK-BR-3 | Palbociclib | 19.9526 | uM | 4 | 312.50 | 180.13 | 180.00 | 247.75 | 0.7265 | -0.0015 |
| SK-BR-3 | Omipalisib | 0.1 | uM | 4 | 312.50 | 180.13 | 167.00 | 247.75 | 0.6741 | -0.1517 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 281.00 | 247.75 | 1.1342 | 1.6300 | |
| SK-BR-3 | Palbociclib | 1 | uM | 4 | 312.50 | 180.13 | 231.00 | 247.75 | 0.9324 | 0.7176 |
| SK-BR-3 | Omipalisib | 3.1623 | uM | 4 | 312.50 | 180.13 | 145.00 | 247.75 | 0.5853 | -0.3760 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 332.00 | 247.75 | 1.3401 | 2.7797 | |
| SK-BR-3 | Omipalisib | 1 | uM | 4 | 312.50 | 180.13 | 116.00 | 247.75 | 0.4682 | -0.6159 |
| SK-BR-3 | Methotrexate | 0.0016596 | uM | 4 | 312.50 | 180.13 | 344.00 | 247.75 | 1.3885 | 3.0831 |
| SK-BR-3 | Palbociclib | 0.01 | uM | 4 | 312.50 | 180.13 | 269.00 | 247.75 | 1.0858 | 1.3919 |
| SK-BR-3 | Taxol | 0.001 | uM | 4 | 312.50 | 180.13 | 251.00 | 247.75 | 1.0131 | 1.0575 |
| SK-BR-3 | Methotrexate | 0.01 | uM | 4 | 312.50 | 180.13 | 305.00 | 247.75 | 1.2311 | 2.1431 |
| SK-BR-3 | Palbociclib | 0.31623 | uM | 4 | 312.50 | 180.13 | 171.00 | 247.75 | 0.6902 | -0.1069 |
| SK-BR-3 | Palbociclib | 0.0033113 | uM | 4 | 312.50 | 180.13 | 241.00 | 247.75 | 0.9728 | 0.8834 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 232.00 | 247.75 | 0.9364 | 0.7338 | |
| SK-BR-3 | Palbociclib | 10 | uM | 4 | 312.50 | 180.13 | 195.00 | 247.75 | 0.7871 | 0.1883 |
| SK-BR-3 | Omipalisib | 0.0016596 | uM | 4 | 312.50 | 180.13 | 169.00 | 247.75 | 0.6821 | -0.1295 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 249.00 | 247.75 | 1.0050 | 1.0220 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 183.00 | 247.75 | 0.7387 | 0.0350 | |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 590.00 | 645.00 | 0.9147 | 0.7912 | |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 644.00 | 645.00 | 0.9985 | 0.9962 | |
| SK-BR-3 | Taxol | 0.00033113 | uM | 4 | 625.00 | 368.38 | 482.00 | 645.00 | 0.7473 | 0.3947 |
| SK-BR-3 | Taxol | 0.31623 | uM | 4 | 625.00 | 368.38 | 283.00 | 645.00 | 0.4388 | -0.2784 |
| SK-BR-3 | Methotrexate | 0.031623 | uM | 4 | 625.00 | 368.38 | 725.00 | 645.00 | 1.1240 | 1.3113 |